ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析

◆英語タイトル:ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15899
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ImmunoGen Inc (IMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of novel antibody-drug conjugates (ADCs) that facilitate targeted therapies for the treatment of cancer. The company is also advancing a new class of indolino-benzodiazepine deoxy ribonucleic acid (DNA)-acting payload agents, namely IGNs. It is investigating its lead product candidate, mirvetuximab soravtansine in Phase 3 clinical trials; and combination of bevacizumab and pembrolizumab in Phase 2 clinical studies for the treatment of platinum-resistant ovarian cancer. ImmunoGen is investigating IMGN779 in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632 for the treatment of AML, and blastic plasmacytoid dendritic cell neoplasm (BPDCN). ImmunoGen is headquartered in Waltham, Massachusetts, the US.

ImmunoGen Inc Key Recent Developments

Mar 01,2019 http://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-top-line-results-phase-3-forward-i-study
Mar 01,2019 ImmunoGen Announces TopLine Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer
Mar 01,2019 ImmunoGen struck by Phase III trial failure in ovarian cancer
Feb 27,2019 ImmunoGen announces multiple presentations at AACR Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ImmunoGen Inc – Key Facts
ImmunoGen Inc – Key Employees
ImmunoGen Inc – Key Employee Biographies
ImmunoGen Inc – Major Products and Services
ImmunoGen Inc – History
ImmunoGen Inc – Company Statement
ImmunoGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ImmunoGen Inc – Business Description
R&D Overview
ImmunoGen Inc – Corporate Strategy
ImmunoGen Inc – SWOT Analysis
SWOT Analysis – Overview
ImmunoGen Inc – Strengths
ImmunoGen Inc – Weaknesses
ImmunoGen Inc – Opportunities
ImmunoGen Inc – Threats
ImmunoGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ImmunoGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2019: http://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-top-line-results-phase-3-forward-i-study
Mar 01, 2019: ImmunoGen Announces TopLine Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer
Mar 01, 2019: ImmunoGen struck by Phase III trial failure in ovarian cancer
Feb 27, 2019: ImmunoGen announces multiple presentations at AACR Annual Meeting
Feb 08, 2019: ImmunoGen reports recent progress and 2018 operating results
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 26, 2018: ImmunoGen announces resignation of Chief Financial Officer
Nov 26, 2018: ImmunoGen announces resignation of chief financial officer
Nov 02, 2018: ImmunoGen reports recent progress and third quarter 2018 operating results
Oct 20, 2018: ImmunoGen Presents Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 Congress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ImmunoGen Inc, Key Facts
ImmunoGen Inc, Key Employees
ImmunoGen Inc, Key Employee Biographies
ImmunoGen Inc, Major Products and Services
ImmunoGen Inc, History
ImmunoGen Inc, Subsidiaries
ImmunoGen Inc, Key Competitors
ImmunoGen Inc, Ratios based on current share price
ImmunoGen Inc, Annual Ratios
ImmunoGen Inc, Annual Ratios (Cont...1)
ImmunoGen Inc, Interim Ratios
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ImmunoGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ImmunoGen Inc, Performance Chart (2014 - 2018)
ImmunoGen Inc, Ratio Charts
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Robert Bosch Healthcare Systems, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Robert Bosch Healthcare Systems, Inc. (Robert Bosch) is a healthcare company. The company develops and distributes telehealth and patient monitoring systems. The company’s products include health buddy telehealth system, T400 telehealth system, and telehealth peripherals among others. It off …
  • Concho Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Concho Resources, Inc. Mergers …
  • UniQuest Pty Ltd:企業のM&A・提携動向(医療分野)
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland. is a business and consumer services company that offers commercialization services. The company commercialises intellectual property and research outcomes of University of Queensland. It provides ways to fast track re …
  • PledPharma AB (PLED):企業の財務及び戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that develops pharmaceutical products for oncology market. The company’s products under clinical development include PP-095, and PP-099. PledPharma’s products are used in the therapeutic areas of cardiology and oncology. It also evaluate …
  • OM Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OM Group, Inc. Mergers and Acqu …
  • Dick’s Sporting Goods, Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "Dick's Sporting Goods, Inc. : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descriptio …
  • Krosaki Harima Corporation:企業の戦略・SWOT・財務情報
    Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report Summary Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Jungheinrich AG:企業の戦略・SWOT・財務情報
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Consumers Energy Company:企業のM&A・提携動向(発電分野)
    Summary Consumers Energy Company (CEC), formerly Consumers Power, is an electric and natural gas utility. It operates as a principal subsidiary of CMS Energy Corporation. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, s …
  • Shigematsu Works Co., Ltd. (7980):企業概要、財務及び戦略的SWOT分析
    Summary Shigematsu Works Co., Ltd. (Shigematsu) is a medical device manufacturer. The company manufactures and sells personal protective equipment, instrument, material, chemical, related to safety and health, disaster prevention (escape, rescue operation, firefighting etc.) in the industrial fields …
  • Agder Energi AS:企業のM&A・提携動向(エネルギー分野)
    Summary Agder Energi AS (Agder Energi) is an energy producer that refines and manages renewable energy. The company generates, distributes and sells energy. It operates through segments such as hydropower, district heating and wind power. Agder Energi provides energy solutions for wind power, hydro …
  • HP Inc.:戦略・SWOT・企業財務分析
    HP Inc. - Strategy, SWOT and Corporate Finance Report Summary HP Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務情報
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Resolution Holdings (UK) Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Resolution Holdings (UK) Limite …
  • MetGen Oy-製薬・医療分野:企業M&A・提携分析
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company provides metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosi …
  • Verdezyne Inc-製薬・医療分野:企業M&A・提携分析
    Summary Verdezyne Inc (Verdezyne) is an industrial biotechnology company that develops and produces chemicals from renewable and non-food sources. The company’s products include adipic acid, dodecanedioic acid and sebacic acid. Its products are used in production of toothbrush bristles and fishing l …
  • Crown Castle International Corp.:企業の戦略・SWOT・財務情報
    Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report Summary Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Vitol Group:企業の戦略・SWOT・財務情報
    Vitol Group - Strategy, SWOT and Corporate Finance Report Summary Vitol Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • Nexon Asia Pacific Pty., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nexon Asia Pacific Pty., Ltd. M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆